Malcolm Hoenlein

CIK 1294517 · last filed 2026-01-05

Malcolm Hoenlein is a corporate insider who has filed 37 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for FBIOP, was dated Jan 5, 2026. Across all open-market trades the lifetime net is +$340.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.18M

Companies

7

Total Filings

37

Lifetime Open-Market Net

$340.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
FBIOP Director 115,747 $18.76 $2.17M $300.0K 10 2026-01-05
DarioHealth Corp. (DRIOW) Delisted Director 78,033 $0 8 2018-06-08
FBIO Director 3,667 $3.39 $12.4K $0 3 2017-07-21
DarioHealth Corp. (DRIO.W) Delisted Director 19,168 $0 1 2016-08-17
Fortress Biotech, Inc. (CNDO) Delisted Director 55,000 $40.2K 2 2014-11-10
KERYX BIOPHARMACEUTICALS INC (KERX) Delisted Director 110,000 $0 3 2008-11-18
TG THERAPEUTICS, INC. (MHA) Delisted Director 4,861 $0 1 2007-04-27

Recent Filings

37 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-01-05 FBIOP Grant (A) +27,322 $0 EDGAR
2025-01-03 FBIOP Grant (A) +49,383 $0 EDGAR
2024-01-03 FBIOP Grant (A) +3,333 $0 EDGAR
2023-01-04 FBIOP Grant (A) +50,000 $0 EDGAR
2022-04-29 FBIOP Mixed +50,636 $0 EDGAR
2021-04-09 FBIOP Grant (A) +50,000 $0 EDGAR
2020-09-01 FBIOP Buy (P) +16,667 $300.0K EDGAR
2020-03-13 FBIOP Grant (A) +50,000 $0 EDGAR
2019-04-12 FBIOP Grant (A) +50,000 $0 EDGAR
2018-11-30 FBIOP Grant (A) +50,000 $0 EDGAR
Showing 110 of 37
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.